Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025International Journal of DentistryOpen Access

Evaluation of the Effect of Escitalopram on Alveolar Bone Levels and Periodontal Parameters: A Case–Control Study

View Full Paper
Ask AI
Bookmark
Share

Authors

AAAyman AhmedEAEhab Azab

Discussion

Loading...

Member takes

Overview

Case-control study reveals escitalopram users show improved periodontal parameters and less bone loss.

Key Points

  • Escitalopram users exhibited significantly lower scores in gingival index, probing depth, and clinical attachment loss than non-users.
  • Radiographic assessments indicated significantly reduced marginal bone loss in the escitalopram group compared to controls.
  • No significant change in plaque index was observed between the two groups under analysis.
  • The study reinforces the potential benefits of escitalopram in enhancing oral health among patients with clinical depression.

Cite This Study

Ahmed et al. (2025) studied this question.

synapsesocial.com/papers/68c23fc3b210217d64797a23https://doi.org/10.1155/ijod/8637908
View Full Paper
Ask AI
Bookmark
Share